Levamisole hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for levamisole hydrochloride and what is the scope of patent protection?

Levamisole hydrochloride is the generic ingredient in one branded drug marketed by Janssen Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for levamisole hydrochloride.

Summary for levamisole hydrochloride

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	1
Raw Ingredient (Bulk) Api Vendors:	106
Clinical Trials:	30
Patent Applications:	6,440
DailyMed Link:	levamisole hydrochloride at DailyMed

Recent Clinical Trials for levamisole hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Jianhua Zhou	Phase 4
LinkDoc Technology (Beijing) Co. Ltd.	Phase 4
Programme National de Lutte contre l'Onchocercose, Republic of the Congo	Phase 2

See all levamisole hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for levamisole hydrochloride

Adjuvants, Immunologic
Antinematodal Agents
Antirheumatic Agents

Anatomical Therapeutic Chemical (ATC) Classes for levamisole hydrochloride

P02CE	Imidazothiazole derivatives
P02C	ANTINEMATODAL AGENTS
P02	ANTHELMINTICS
P	Antiparasitic products, insecticides and repellents

US Patents and Regulatory Information for levamisole hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Pharma	ERGAMISOL	levamisole hydrochloride	TABLET;ORAL	020035-001	Jun 18, 1990		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for levamisole hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharma	ERGAMISOL	levamisole hydrochloride	TABLET;ORAL	020035-001	Jun 18, 1990	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.